J
Jan Lerut
Researcher at Université catholique de Louvain
Publications - 6
Citations - 380
Jan Lerut is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Milan criteria & Liver transplantation. The author has an hindex of 6, co-authored 6 publications receiving 264 citations. Previous affiliations of Jan Lerut include Catholic University of Leuven.
Papers
More filters
Journal ArticleDOI
Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.
Xavier Muller,F. Marcon,Gonzalo Sapisochin,Max Marquez,Federica Dondero,Michel Rayar,Majella B. Doyle,Lauren Callans,Jun Li,Greg Nowak,Marc Antoine Allard,Ina Jochmans,Kyle Jacskon,Magali Chahdi Beltrame,Marjolein van Reeven,Samuele Iesari,Alessandro Cucchetti,Hemant Sharma,Hemant Sharma,Roxane D Staiger,Dimitri A. Raptis,Henrik Petrowsky,Michelle L. de Oliveira,Roberto Hernandez-Alejandro,Roberto Hernandez-Alejandro,Antonio Daniele Pinna,Jan Lerut,Wojciech G. Polak,Eduardo de Santibañes,Martin de Santibañes,Andrew M. Cameron,Jacques Pirenne,Daniel Cherqui,René Adam,Bo Göran Ericzon,Bjoern Nashan,Kim M. Olthoff,Avi Shaked,William C. Chapman,Karim Boudjema,Olivier Soubrane,Catherine Paugam-Burtz,Paul D. Greig,David R. Grant,Amanda Carvalheiro,Paolo Muiesan,Philipp Dutkowski,Milo A. Puhan,Pierre-Alain Clavien +48 more
TL;DR: Despite excellent 1- year survival, morbidity in benchmark cases remains high with half of patients developing severe complications during 1-year follow-up, and benchmark cutoffs targeting morbidity parameters offer a valid tool to assess higher risk groups.
Journal ArticleDOI
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
Quirino Lai,Alessandro Vitale,Samuele Iesari,Armin Finkenstedt,Gianluca Mennini,Gabriele Spoletini,Maria Hoppe-Lotichius,Giovanni Vennarecci,Tommaso Maria Manzia,Daniele Nicolini,Alfonso Wolfango Avolio,Anna Chiara Frigo,Ivo Graziadei,Massimo Rossi,Emmanouil Tsochatzis,Gerd Otto,Giuseppe Maria Ettorre,Giuseppe Tisone,Marco Vivarelli,Salvatore Agnes,Umberto Cillo,Jan Lerut +21 more
TL;DR: The ITT transplant survival benefit presented here allows physicians to better select HCC patients waiting for liver transplantation (LT) and may lead to an improved and more equitable method of organ allocation.
Journal ArticleDOI
A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score.
Quirino Lai,Daniele Nicolini,Milton Inostroza Nunez,Samuele Iesari,Pierre Goffette,Andrea Agostini,Andrea Giovagnoni,Marco Vivarelli,Jan Lerut +8 more
TL;DR: A novel and easy prognostic score based on the combination of pre-operatively available variables in patients with hepatocellular cancer waiting for liver transplantation (LT) has been developed from a long waiting time (WT) training set and validated in a short-WT set.
Journal ArticleDOI
Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?
TL;DR: This chapter aims to give a comprehensive overview of the actual literature related to the impact of different immunosuppressive drugs and schemes on outcome of LT in HCC recipients, and the strategy of curtailing and minimising IS should be explored in the growing field of transplant oncology.
Journal ArticleDOI
Des-Gamma-Carboxy Prothrombin in Hepatocellular Cancer Patients Waiting for Liver Transplant: A Systematic Review and Meta-Analysis:
TL;DR: The meta-analysis enabled us to underline the importance of DCP in the refinement of the eligibility criteria of HCC patients for LT, indicating a 5-fold increased risk for HCC recurrence after LT.